SMARTDOSE
DEAD

Serial Number

88677074

Owner

West Pharma. Services IL, Ltd.

Attorney

Rex A. Donnelly

Filing Date

Nov 1, 2019

Add to watchlist:

No watchlists yet
View on USPTO

SMARTDOSE Trademark

Serial Number: 88677074

SMARTDOSE is a trademark filed by West Pharma. Services IL, Ltd. on November 1, 2019. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 38 (Telecommunications), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently no longer active.

Owner Contact Info

West Pharma. Services IL, Ltd. (16 trademarks)

Ra'anana 4366411 , IL

Entity Type: 03

Trademark Details

Filing Date

November 1, 2019

Registration Date

Not Registered

Published for Opposition

June 1, 2021

Goods & Services

downloadable computer application software for mobile phones and handheld computers, namely, interactive patient engagement and medication adherence software for users of wearable injector drug delivery systems; downloadable computer software for facilitating communication between a computer or handheld device connected to the internet and an wearable injector drug delivery system; downloadable mobile applications for communicating with an wearable injector drug delivery system and for displaying health related information

telecommunications services, namely, providing e-mail and text messages notification via the internet, featuring alerts, reminders and information related to compliance with health programs relating to wearable injector drug delivery systems

Infusion pumps, sold pre-filled, for facilitating subcutaneous delivery of a wide range of liquid pharmaceutical preparations to patients; infusion pumps sold pre-filled with fluids used for the subcutaneous delivery of pharmaceutical preparations to patients; infusion pumps for delivering liquid pharmaceutical preparations to patients, sold pre-filled with pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; infusion pumps for delivering liquid pharmaceutical preparations to patients, sold pre-filled with insulin

arranging and conducting incentive reward programs for promoting consumer compliance with prescriptions for medications delivered by wearable injector drug delivery systems; promoting data collection used in improving healthcare administration and cost management in connection with wearable injector drug delivery systems by providing an interactive web site where users can provide information about health and fitness in the nature of their health programs, personal health data and prescription and health conditions, in exchange for promotional rewards consisting of discounts and special offerings on goods and/or services provided by website sponsors

Providing health care information relating to wearable injector drug delivery systems by global computer networks and electronic means

Computer services, namely, providing an interactive web site featuring technology that allows users to communicate information from wearable injector drug delivery systems; Providing temporary use of non-downloadable computer software for communicating with wearable injector drug delivery systems and for displaying health related information; Providing an interactive web site featuring technology that enables users to enter, access, track, monitor and generate health and medical information and reports relating to wearable injector drug delivery systems; Providing on-line non-downloadable software for authenticating and rewarding compliance with health programs, namely, prescriptions for medications and medical treatment regimens related to wearable injector drug delivery systems; Providing on-line non-downloadable software for users to receive notifications via e-mail, instant message, short message service (SMS), multimedia message service (MMS) or text messages relating to wearable injector drug delivery systems; Research and development and consultation related thereto in the field of wearable injector drug delivery systems

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Mar 4, 2024 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Mar 4, 2024 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 29, 2023 EXRA
SOU EXTENSION 4 GRANTED
Jul 27, 2023 EX4G
SOU EXTENSION 4 FILED
Jul 27, 2023 EXT4
SOU TEAS EXTENSION RECEIVED
Jul 27, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 6, 2023 EXRA
SOU EXTENSION 3 GRANTED
Jan 4, 2023 EX3G
SOU EXTENSION 3 FILED
Jan 4, 2023 EXT3
SOU TEAS EXTENSION RECEIVED
Jan 4, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 29, 2022 EXRA
SOU EXTENSION 2 GRANTED
Jul 27, 2022 EX2G
SOU EXTENSION 2 FILED
Jul 27, 2022 EXT2
SOU TEAS EXTENSION RECEIVED
Jul 27, 2022 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 28, 2022 EXRA
SOU EXTENSION 1 GRANTED
Jan 26, 2022 EX1G
SOU EXTENSION 1 FILED
Jan 26, 2022 EXT1
SOU TEAS EXTENSION RECEIVED
Jan 26, 2022 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jul 27, 2021 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 1, 2021 NPUB
PUBLISHED FOR OPPOSITION
Jun 1, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 12, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 23, 2021 CNSA
EXAMINER'S AMENDMENT ENTERED
Apr 21, 2021 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Apr 21, 2021 GNEN
EXAMINERS AMENDMENT E-MAILED
Apr 21, 2021 GNEA
EXAMINERS AMENDMENT -WRITTEN
Apr 21, 2021 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 8, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 8, 2021 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Apr 8, 2021 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Oct 14, 2020 GNFN
FINAL REFUSAL E-MAILED
Oct 14, 2020 GNFR
FINAL REFUSAL WRITTEN
Oct 14, 2020 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 15, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 14, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 14, 2020 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 14, 2020 GNRN
NON-FINAL ACTION E-MAILED
Feb 14, 2020 GNRT
NON-FINAL ACTION WRITTEN
Feb 14, 2020 CNRT
ASSIGNED TO EXAMINER
Feb 6, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 6, 2019 NWOS
NEW APPLICATION ENTERED
Nov 5, 2019 NWAP